Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2161 POSTS 0 COMMENTS

https://psynews.com

Transforming Trauma: Community, Connection, and the Healing Power of Vulnerability

Women and Psychedelics: History’s Untold Stories

Pα+ Psychedelic Bulletin #165: A Closer Look at a Buzzy Oral...

Understanding Microdosing: Integrating Small Doses for Big Therapeutic Gains

In Brief: ICER Issues Final Evidence Report and Recommendations Re: MDMA-Assisted...

Building a Unified Psychedelic Future: Ethics, Standards, and a Path to...

What is MDMA’s FDA Approval Status? A Look Ahead

No NHS Coverage for Janssen’s Spravato: NICE Denies Re-Appraisal of Esketamine...

Natural Medicine Advisory Bulletin 11.6: June 14th Subcommittee: Problems with Products

Spirituality: An Essential Understanding for Psychedelic Integration

1...151617...217 Page 16 of 217

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

From Fringe to Focus: APA’s American Journal of Psychiatry Publishes Special...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin